Quick Answer
Century Therapeutics, Inc. reported Net Income Loss of -$9.58 million for the year ending 2025.
- Century Therapeutics, Inc. showed an increase of +92.4% in Net Income Loss from 2024 to 2025.
- This data is from Century Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Century Therapeutics, Inc.'s Net Income Loss has grown by 82.1%.
- Historical annual values: Fiscal year 2025: -$9.58 million | Fiscal year 2024: -$126.57 million | Fiscal year 2023: -$136.67 million | Fiscal year 2022: -$130.93 million | Fiscal year 2021: -$95.82 million | Fiscal year 2020: -$53.58 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: